Bruker expects FY 2026 non-GAAP EPS of $2.10-$2.15 while targeting 250-300 bps operating margin expansion

• "Bruker's positive bookings trends continued in the fifth consecutive quarter of Bruker Scientific Instruments or BSI book-to-bill greater than 1" (Chairman, CEO & President Frank Laukien), alongside end-market callouts that "BSI organic bookings in the U.S. Acad/Gov market

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.